Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe phrase "viogen semaglutide 10mg pen" appears in a lot of searches, and it's worth being direct about what it refers to. Semaglutide for weight loss is licensed in the UK as Wegovy, supplied by Novo Nordisk — not as a product called Viogen, and not in a 10mg pen. If you've seen this term advertised online, the most likely explanation is either a compounded or unregulated product sold outside the licensed supply chain, or straightforward confusion with a different medicine. Either way, understanding the distinction matters, because semaglutide is a Prescription-Only Medicine (POM) in the UK and its supply is regulated accordingly. A prescriber must assess your suitability before any legitimate supply can happen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scenario: you're researching weight-loss injections, you come across the name Viogen semaglutide 10mg in a sponsored post or a forum thread, and you want to know whether it's legitimate before spending any money. That's a sensible instinct.
Licensed Wegovy pens in the UK run through a precise dose ladder, 0.25mg, 0.5mg, 1.0mg, 1.7mg, and 2.4mg, with the recently approved higher-dose option reaching 7.2mg. Those are the only strengths that have passed through MHRA scrutiny and carry a UK marketing authorisation. A 10mg semaglutide pen doesn't exist anywhere in that ladder. The Wegovy dose range is set by the clinical programme that demonstrated safety and effectiveness; it doesn't scale to 10mg because the licensed development programme never went there.
The name Viogen adds a second layer of concern. It does not correspond to any MHRA-registered brand for semaglutide. When an unfamiliar brand name appears attached to a prescription medicine (especially one being offered at high doses, sometimes via social media or online marketplaces) that combination is exactly what regulators warn about. The MHRA has seized large quantities of fake weight-loss pens in the UK, some containing entirely wrong active substances. Reporting any suspect product or seller at the MHRA's Yellow Card scheme takes two minutes and contributes to enforcement action.
If you've already purchased something labelled this way, stop using it and speak to a pharmacist or your GP.
There's a separate explanation for the 10mg figure that's worth being honest about. Compounding pharmacies (which exist outside the standard licensed supply chain) sometimes prepare semaglutide at concentrations described in milligrams per vial or per millilitre, resulting in dose descriptions that look nothing like the Wegovy ladder. Separately, peptide suppliers operating in a legal grey area (or outright illegally) sell "research-grade" semaglutide in quantities expressed in milligrams, sometimes marketed with brand names like Viogen.
Neither of these is equivalent to licensed Wegovy. The peptide semaglutide market sits entirely outside MHRA regulation for human use; products sold through it have not been assessed for safety, potency, or sterility in the way a licensed medicine must be. Choosing one to save money or avoid a prescription is not a shortcut, it removes every layer of protection the licensing process exists to provide.
For patients researching what a 10mg semaglutide dosage chart might look like, it's also worth noting that no such chart exists within licensed UK practice. The dose you'd be working from has no clinical basis in the UK weight-management setting.
Keep the pen in a specific spot (a shelf in the fridge door works well for many patients) so the routine sticks. That kind of consistency matters more with a licensed product that comes with clear storage instructions; it's harder to apply to an unlicensed vial with no patient information leaflet.
Licensed Wegovy is prescribed following a clinical assessment, dispensed by a GPhC-registered pharmacy, and supplied in pre-filled Novo Nordisk pens with a full Patient Information Leaflet. That leaflet covers storage, what to do with missed doses, and side effects, information that simply doesn't exist for unlicensed products.
The dose ladder starts at 0.25mg weekly and moves upward in steps, typically over several months. You can read more about how the Wegovy dose schedule works and, if you're wondering about timing between steps, whether moving up before four weeks is ever appropriate. These are decisions a prescriber makes based on how your body is responding, they're not a matter of personal preference or arbitrary rules.
The NHS medicines pages for semaglutide describe what the medicine does, common side effects (predominantly gastrointestinal: nausea, diarrhoea, constipation and related symptoms, usually settling over time), and who shouldn't use it. That's a useful baseline read before any consultation.
If you're eligible (broadly, adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition) a private prescription route means no NHS waiting list. You can explore what a private Wegovy prescription typically costs in the UK, and what a transparent price should include. For a prescription medicine, the measure that keeps you safe isn't the cheapest listing you can find, it's whether the product is genuine, the prescriber is qualified, and the pharmacy is registered.
If you'd like a clinician to assess your suitability, our team is available. Speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.